Unavailable
Unavailable
Save time and jump to the most important pieces.
SC 13G/A - Spectaire Holdings Inc. (0001844149) (Subject)
SC 13G/A - Spectaire Holdings Inc. (0001844149) (Subject)
SC 13G/A - Spectaire Holdings Inc. (0001844149) (Subject)
4/A - Spectaire Holdings Inc. (0001844149) (Issuer)
4 - Spectaire Holdings Inc. (0001844149) (Issuer)
4 - Spectaire Holdings Inc. (0001844149) (Issuer)
EFFECT - Spectaire Holdings Inc. (0001844149) (Filer)
S-1/A - Spectaire Holdings Inc. (0001844149) (Filer)
S-1/A - Spectaire Holdings Inc. (0001844149) (Filer)
WATERTOWN, Mass. and MINNEAPOLIS, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Spectaire Inc. ("Spectaire" or "Company"), a provider of cutting-edge solutions for customers to monitor, track and meet emissions targets via its patented micro-mass-spectrometer (MMS) device AireCore™, today announced the closing of its previously announced business combination (the "Transaction") with Perception Capital Corp. II ("Perception"), a special purpose acquisition company. The combined company will operate under the name "Spectaire Holdings Inc." ("Spectaire Holdings"). Beginning on October 20, 2023, Spectaire Holdings will commence trading of its common stock and warrants on the Nasdaq Stock Market under the
WATERTOWN, Mass. and WAYZATA, Minn., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Spectaire Inc. ("Spectaire" or "Company"), a provider of cutting-edge solutions for customers to monitor, track and meet emissions targets via its patented micro-mass-spectrometer (MMS) device, and Perception Capital Corp. II (NASDAQ:PCCT) ("Perception"), today announced that Perception has entered into a private placement subscription agreement (the "PIPE Subscription Agreement") with Dr. Jörg Mosolf (the "PIPE Investor"), the chairman of Mosolf SE & Co. KG ("Mosolf") and a director of Spectaire, for an aggregate purchase price of $3,500,000 in connection with the proposed business combination between Spectaire and Per
Positioned to Meet Growing Customer Demand for Accurate, Real-Time Emissions Data to Smooth the Global Energy Transition Combination Will Allow Spectaire to Pursue Significant Market Opportunity. The proposed business combination is expected to allow Spectaire to better fulfill growing demand for monitoring and measurement technology needed to meet emissions reduction commitments. Customers are able to save money and generate carbon credits by relying on Spectaire's accurate, real-time data, rather than online estimating tools, which can overstate emissions by up to 60%. No Viable Competitors. We believe that Spectaire's micro-mass-spectrometer (MMS) device is the world's first and only
Gainers SeaStar Medical Holding Corporation (NASDAQ:ICU) shares climbed 36.4% to $1.0516. SeaStar medical shares jumped 70% on Wednesday after the FDA granted the company's Selective Cytopheretic Device Breakthrough Device Designation for hepatorenal syndrome. Outlook Therapeutics, Inc. (NASDAQ:OTLK) jumped 33.6% to $0.6304. MMTec, Inc. (NASDAQ:MTC) rose 32% to $1.7929. Atreca, Inc. (NASDAQ:BCEL) shares gained 28.8% to $0.3490. On Sept. 21, Atreca announced the termination of the lease at its corporate headquarters and the departure of the company's CFO. Spectral AI, Inc. (NASDAQ:MDAI) gained 26.7% to $3.2803. Spectral AI said that its DeepView SnapShot® Wound Imaging System is now
Spectaire Inc. ("Spectaire" or "Company"), a provider of cutting-edge solutions for customers to monitor, track and meet emissions targets via its patented micro-mass-spectrometer (MMS) device, and Perception Capital Corp. II (NASDAQ:PCCT) ("Perception"), today announced that Perception has entered into a private placement subscription agreement (the "PIPE Subscription Agreement") with Dr. Jörg Mosolf (the "PIPE Investor"), the chairman of Mosolf SE & Co. KG ("Mosolf") and a director of Spectaire, for an aggregate purchase price of $3,500,000 in connection with the proposed business combination between Spectaire and Perception (the "Transaction"). The Company also announced that it has recei